Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Meta-analysis of the association between urokinase-plasminogen activator gene rs2227564 polymorphism and Alzheimer's disease.

American journal of Alzheimer's disease and other dementias - 1 Aug 2013

Wu Wenlong, Jiang Hong, Wang Meiyun, Zhang Dongfeng

Abstract excerpt

OBJECTIVE: The association between urokinase-plasminogen activator (PLAU) gene rs2227564 polymorphism and Alzheimer's disease (AD) risk has been widely reported across different ethnic populations, with inconsistent results. Thus, we performed a meta-analysis to assess the association between PLAU rs2227564 polymorphism and AD risk. METHODS: Fixed or random effect model was used as the pooling method to assess...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alleles
Share to Alzheimer Disease
Share to Genetic Predisposition to Disease
Share to Genotype
Share to Heterozygote
Share to Polymorphism, Genetic
Share to Risk
Share to Urokinase-Type Plasminogen Activator

Source

Open in PubMed Open full text

Identifiers

PMID: 23813610
DOI: 10.1177/1533317513494450
PMCID: PMC10852686

Genes

PLAU

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Meta-analysis of the association between urokinase-plasminogen activator gene rs2227564 polymorphism and Alzheimer's disease.PMID 23813610Read ↗

A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.Semantic proximity Read ↗

Association of tagSNPs in the urokinase-plasminogen activator (PLAU) gene with Alzheimer's disease and associated quantitative traits.Semantic proximity Read ↗

Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease.Semantic proximity Read ↗

Association of PS1 1/2, ACE I/D, and LRP C/T polymorphisms with Alzheimer's disease in the Chinese population: a meta-analysis of case-control studies.Semantic proximity Read ↗

Influence of four polymorphisms in ABCA1 and PTGS2 genes on risk of Alzheimer's disease: a meta-analysis.Semantic proximity Read ↗

Meta-analyses of 8 polymorphisms associated with the risk of the Alzheimer's disease.Semantic proximity Read ↗

Cyclooxygenase-2 gene polymorphisms and risk of Alzheimer's disease: A meta-analysis.Semantic proximity Read ↗

CYP46A1 intron-2T/C polymorphism and Alzheimer's disease: an updated meta-analysis of 16 studies including 3,960 cases and 3,828 controls.Semantic proximity Read ↗

The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.Semantic proximity Read ↗

Association of insulin degrading enzyme gene polymorphisms with Alzheimer's disease: a meta-analysis.Semantic proximity Read ↗

Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2.Semantic proximity Read ↗

Alpha 2-Macroglobulin Polymorphisms and Susceptibility to Alzheimer’s Disease: A Comprehensive Meta-Analysis Based on 62 StudiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.